Dr.Ronit Pressler
Ronit is Consultant in Clinical Neurophysiology and clinical lead of the Telemetry Unit at Great Ormond Street Hospital for children, London and Associated Professor at the UCL-Institute of Child Health. She qualified from Berlin University in 1992 and trained in paediatrics in Berlin, Germany and clinical neurophysiology at the National Hospital for Neurology and Neurosurgery, London, obtaining her MD in 1997 and her PhD in 2006.
Her research interests include neonatal seizures, particularly their diagnosis and treatment, as well as the effect of epilepsy on cognition and pre-surgical evaluation in children with complex epilepsy. Since 2015 she has been on the council of the British Society for Clinical Neurophysiology BSCN) and currently severs as international secretary. She is also affiliated member of the Paediatric Neuroscience Clinical Reference Group, NHS England. She has an international reputation for teaching neonatal EEG and is director of the ILAE EEG course ‘EEG in the first year of life’. She is chair of the ILAE neonatal seizure classification task force as well as co-chair of the ILAE neonatal guidelines task force.
Dr. Richard Chin
Dr. Chin is Reader (Associate Professor) in Paediatric Neurosciences and Director of the Muir Maxwell Epilepsy Centre at the University of Edinburgh; and clinically active Honorary Consultant Paediatric Neurologist at the Royal Hospital for Sick Children, Edinburgh. His initial medical training was at the University of the West Indies, Jamaica before taking up a Commonwealth Fellowship in paediatric neurology at Great Ormond Street Hospital in London, where he also completed his clinical training in paediatric neurology. He obtained his PhD at University College London. His research programme is centred around the clinical and epidemiological aspects of childhood epilepsy and convulsive status epilepticus. He has been PI on clinical trials of cannabidiol in epileptic encephalopathies.
Prof. Arthur Burghes
Professor Arthur Burghes received his Ph.D. in Biochemistry from the University of London. He performed his graduate work at the Hammersmith Hospital which lies adjacent to Wormwood Scrubs Her Majesty’s prison service, which he did not attend. He then moved to the Hospital for Sick Children in Toronto under the direction of Dr. Worton and was involved in cloning the dystrophin gene. He then moved to take up an Assistant Professor position in the Department of Biological Chemistry and Pharmacology where he started his work on Spinal Muscular Atrophy. At The Ohio State University, he has risen through the ranks to Professor, irritated administrators, and undertaken research in SMA that has led to the current era of treatments. In particular he was involved in early mapping studies to identify the location of the gene, characterization of the role of SMN2 in modifying the disease phenotypes as well as the development of animal model both of SMA both mice and pigs. This has transitioned into successful treatment in SMA patients including gene therapy for SMA.